Druais, S., Doutriaux, A., Cognet, M., Godet, A., Lançon, C., Levy, P., . . . Guillon, P. (2016). Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France. Pharmacoeconomics.
Chicago Style aipamenaDruais, Sylvain, Agathe Doutriaux, Magali Cognet, Annabelle Godet, Christophe Lançon, Pierre Levy, Ludovic Samalin, and Pascal Guillon. "Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France." Pharmacoeconomics 2016.
MLA aipamenaDruais, Sylvain, et al. "Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France." Pharmacoeconomics 2016.